Cantel Medical is up about 30% this year on investor enthusiasm for its sales growth in endoscopy, as well as a brisk acquisition strategy. But its shares were down about 1% in early trading on Dec. 10 after the company reported first quarter earnings that missed expectations a bit.
Recipharm, a Swedish contract development manufacturer, said it may be forced to eliminate up to 60 jobs and close one of its plants after Meda, a specialty pharmaceutical group, opted to drop one of its contracts with the company.
SetPoint Medical is starting a clinical trial to treat Crohn's disease patients with its implantable neuromodulation device. The startup previously reported a positive pilot study of the device to treat rheumatoid arthritis.
Pixium Vision, which had its IPO in June, is ready to head to European regulators with a retinal implant.
In this week's EuroBiotech Report, weeks after being criticized for encouraging profit-shifting, the United Kingdom unveiled plans to discourage multinationals from funneling money out of the country. The law--dubbed the "Google tax"--is targeted at multinational tech giants but could snare Big Pharma, too. And more.
To address the European Commission's concerns about its proposed $13.4 billion acquisition of Biomet, Zimmer Holdings has proposed the divestiture of "one unicompartmental knee brand and one elbow brand" in the European Economic Areas as well as "one total knee brand" in two European countries.
iRhythm has received a CE mark in Europe for its continuous heart monitoring Zio Service. The technology enables up to 14 days of continuous heart monitoring via a wireless patch; it includes analytical software, as well as report to the physician. In addition, iRhythm has partnered with cardiology distributor CardioLogic to market Zio in the U.K. for the diagnosis of atrial fibrillation and other cardiac arrhythmias.
Swiss med tech Xeltis has raised €27 million ($34 million) in an oversubscribed Series B round. The financing will be used mostly to help get its first product to market, a biodegradable pulmonary valve intended for patients with severe congenital malformations of the heart, an orphan pediatric indication.
Italian authorities last week began recalling two lots of Novartis' influenza vaccine Fluad after more than a dozen deaths were reported in people who had taken the vaccine. But on Monday the Italian Pharmaceutical Agency cleared the manufacturing of the vaccines, saying that the initial analyses of the lots came back "negative."
Japanese drugmaker Eisai opened two new plants--one targeting products for Asia and the other aimed at Europe--as part of its plans to expand its global manufacturing operations.